Menu
Pulmonology / Respiratory

Narcotic-Induced Central Sleep Apnea

ICD-10 Code
G47.31_2

Clinical Criteria for Narcotic-Induced Central Sleep Apnea.

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents for evaluation of sleep-disordered breathing in the setting of chronic opioid therapy. Reports witnessed apneas, nocturnal gasping, and excessive daytime somnolence (EDS). Current opioid regimen: [Drug Name/Dose/Frequency]. No history of primary OSA; symptoms correlate temporally with initiation or dose escalation of opioid analgesics. Denies morning headaches or significant weight gain.

Clinical Examination Findings

General: Patient is alert and oriented, appears fatigued. HEENT: Oropharynx shows Mallampati score [I-IV], no significant tonsillar hypertrophy or retrognathia. Cardiovascular: Regular rate and rhythm, no murmurs. Pulmonary: Clear to auscultation bilaterally, no wheezing or crackles. Neurological: Normal gait and coordination, pupils reactive to light, no focal deficits. BMI: [Value] kg/m².

Treatment Protocol

1. Opioid dose reduction or rotation to non-opioid analgesics if clinically feasible. 2. Initiate PAP therapy (CPAP or ASV) as indicated by titration study. 3. Avoidance of concomitant sedative-hypnotics or alcohol. 4. Close monitoring of respiratory status and oxygen saturation. 5. Referral to pain management specialist for optimization of non-pharmacological pain control.

Detailed clinical guide coming soon.